References
- Jafarinejad-Farsangi, S., A. Farazmand, M. Mahmoudi, et al. 2015. MicroRNA-29a induces apoptosis via increasing the Bax:Bcl-2 ratio in dermal fibroblasts of patients with systemic sclerosis. Autoimmunity. [Epub ahead of print]. doi: 10.3109/08916934.2015.1030616
- Ciechomska, M., S. O’Reilly, M. Suwara, et al. 2014. MiR-29a reduces TIMP-1 production by dermal fibroblasts via targeting TGF-β activated kinase 1 binding protein 1, implications for systemic sclerosis. PLoS One 9: e115596
- Mott, J. L., S. Kobayashi, S. F. Bronk, and G. J. Gores. 2007. mir-29 regulates Mcl-1 protein expression and apoptosis. Oncogene 26: 6133–6140
- Xiong, Y., J.-H. Fang, J.-P. Yun, et al. 2010. Effects of MicroRNA-29 on apoptosis, tumorigenicity, and prognosis of hepatocellular carcinoma. Hepatology 51: 836–845
- Chizzolini, C., Y. Parel, C. De Luca, et al. 2003. Systemic sclerosis Th2 cells inhibit collagen production by dermal fibroblasts via membrane-associated tumor necrosis factor α. Arthritis Rheum. 48: 2593–2604
- Miyazaki, Y., K. Araki, C. Vesin, et al. 1995. Expression of a tumor necrosis factor-alpha transgene in murine lung causes lymphocytic and fibrosing alveolitis. A mouse model of progressive pulmonary fibrosis. J. Clin. Investig. 96: 250–259
- Hügle, T., S. O’Reilly, R. Simpson, et al. 2013. Tumor necrosis factor – costimulated T lymphocytes from patients with systemic sclerosis trigger collagen production in fibroblasts. Arthritis Rheum. 65: 481–491
- Millar, N. L., D. S. Gilchrist, M. Akbar, et al. 2015. MicroRNA29a regulates IL-33-mediated tissue remodelling in tendon disease. Nat. Commun. 6: 6774
- Xiao, J., X.-M. Meng, X. R. Huang, et al. 2012. miR-29 inhibits bleomycin-induced pulmonary fibrosis in mice. Mol. Ther. 20: 1251–1260